广州医科大学学报
廣州醫科大學學報
엄주의과대학학보
Academic Journal of Guangzhou Medical College
2015年
4期
66-68,78
,共4页
方兴%严文康%郑欣%蓝博文%张坤尧
方興%嚴文康%鄭訢%藍博文%張坤堯
방흥%엄문강%정흔%람박문%장곤요
高胆红素血症%脑损伤%核磁共振%新生儿胆红素脑病%足月儿
高膽紅素血癥%腦損傷%覈磁共振%新生兒膽紅素腦病%足月兒
고담홍소혈증%뇌손상%핵자공진%신생인담홍소뇌병%족월인
hyperbilirubinemia%brain injury%MR%neonatal bilirubin encephalopathy%full-term infant
目的::探讨MRI对亚临床胆红素脑损伤诊断的价值。方法:回顾性分析2012年1月至2014年12月本院收治的130例高胆红素血症但未达到胆红素脑病诊断标准(亚临床胆红素脑损伤)的新生儿的临床资料,按MRI有无发现苍白球对称性T1W1高信号改变分为脑损伤组(52例)及非脑损伤组(78例),比较两组胆红素水平、头颅 MRI 表现、神经发育情况。结果:脑损伤组的血清总胆红素、间接胆红素、直接胆红素等指标均显著高于非脑损伤组(P<0.01);脑损伤组例数随着血清总胆红素水平升高而增加,STB≥513μmol/L者占88.5%,明显高于非脑损伤组(P<0.01);治疗后两组患儿贝利婴幼儿发育量表MDI、PDI等评估指标均有提高,而脑损伤组 MDI、PDI等指标水平提升幅度显著高于非脑损伤组( P<0.01),两组比较差异无统计学意义(P>0.05);治疗后脑损伤组MDI、PDI值≥85分者分别占90.4%、86.5%,显著高于非脑损伤组(P<0.05)。结论:血清胆红素浓度与脑损伤密切相关;血清总胆红素513μmol/L可作为引起亚临床胆红素脑损伤的阈值。对达到亚临床胆红素脑损伤阈值的新生儿应及时进行早期干预,以避免亚临床胆红素脑损伤的出现。头颅MRI检查可及时发现亚临床胆红素脑损伤,早期干预治疗可改善其预后。
目的::探討MRI對亞臨床膽紅素腦損傷診斷的價值。方法:迴顧性分析2012年1月至2014年12月本院收治的130例高膽紅素血癥但未達到膽紅素腦病診斷標準(亞臨床膽紅素腦損傷)的新生兒的臨床資料,按MRI有無髮現蒼白毬對稱性T1W1高信號改變分為腦損傷組(52例)及非腦損傷組(78例),比較兩組膽紅素水平、頭顱 MRI 錶現、神經髮育情況。結果:腦損傷組的血清總膽紅素、間接膽紅素、直接膽紅素等指標均顯著高于非腦損傷組(P<0.01);腦損傷組例數隨著血清總膽紅素水平升高而增加,STB≥513μmol/L者佔88.5%,明顯高于非腦損傷組(P<0.01);治療後兩組患兒貝利嬰幼兒髮育量錶MDI、PDI等評估指標均有提高,而腦損傷組 MDI、PDI等指標水平提升幅度顯著高于非腦損傷組( P<0.01),兩組比較差異無統計學意義(P>0.05);治療後腦損傷組MDI、PDI值≥85分者分彆佔90.4%、86.5%,顯著高于非腦損傷組(P<0.05)。結論:血清膽紅素濃度與腦損傷密切相關;血清總膽紅素513μmol/L可作為引起亞臨床膽紅素腦損傷的閾值。對達到亞臨床膽紅素腦損傷閾值的新生兒應及時進行早期榦預,以避免亞臨床膽紅素腦損傷的齣現。頭顱MRI檢查可及時髮現亞臨床膽紅素腦損傷,早期榦預治療可改善其預後。
목적::탐토MRI대아림상담홍소뇌손상진단적개치。방법:회고성분석2012년1월지2014년12월본원수치적130례고담홍소혈증단미체도담홍소뇌병진단표준(아림상담홍소뇌손상)적신생인적림상자료,안MRI유무발현창백구대칭성T1W1고신호개변분위뇌손상조(52례)급비뇌손상조(78례),비교량조담홍소수평、두로 MRI 표현、신경발육정황。결과:뇌손상조적혈청총담홍소、간접담홍소、직접담홍소등지표균현저고우비뇌손상조(P<0.01);뇌손상조례수수착혈청총담홍소수평승고이증가,STB≥513μmol/L자점88.5%,명현고우비뇌손상조(P<0.01);치료후량조환인패리영유인발육량표MDI、PDI등평고지표균유제고,이뇌손상조 MDI、PDI등지표수평제승폭도현저고우비뇌손상조( P<0.01),량조비교차이무통계학의의(P>0.05);치료후뇌손상조MDI、PDI치≥85분자분별점90.4%、86.5%,현저고우비뇌손상조(P<0.05)。결론:혈청담홍소농도여뇌손상밀절상관;혈청총담홍소513μmol/L가작위인기아림상담홍소뇌손상적역치。대체도아림상담홍소뇌손상역치적신생인응급시진행조기간예,이피면아림상담홍소뇌손상적출현。두로MRI검사가급시발현아림상담홍소뇌손상,조기간예치료가개선기예후。
Objective:To investigate the diagnostic value of magnetic resonance imaging ( MRI ) in subclinical bilirubin brain damage. Methods: A retrospective analysis was conducted of clinical data from 130 newborns with hyperbilirubinemia but not fulfilling the diagnostic criteria for bilirubin encephalopathy ( subclinical bilirubin brain damage) in our hospital between January 2012 and December 2014. According to the presence of symmetric high signal at globus pallidus on T1W1-weighted MRI, the newborns were devided into brain injury group (n=52) and non-brain injury group (n=78). The two groups were compared for bilirubin levels, brain MRI findings, and nerve development. Results:The levels of serum total bilirubin ( STB) , indirect bilirubin and direct bilirubin were significantly higher in the brain injury group than those in the non-brain injury group ( P<0.01) . The number of newborns with brain injury increased with higher total serum bilirubin levels. 88. 5% of all brain injury cases having STB≥513μmol/L, and this rate was significantly higher than as found for the non-brain injury group (P<0.01). After treatment, the values of PDI and MDI in Bailey Infant Development Scale were increased in both groups. While the increases in MDI and PDI were greater in the brain injury group than in the non-brain injury group ( P<0.01) , the absolute values of these two indexes were comparable between groups after treatment (P>0.05). The proportions of newborns with post-treatment PDI and MDI≥85 were significantly higher in the brain injury group (90.4% and 86.5%, respectively) than those in the non-brain injury group ( P<0.05) . Conclusion:The serum bilirubin level is closely related to brain injury. A serum total bilirubin of 513μmol/L can be used as a threshold for subclinical bilirubin brain damage. Newborns with this threshold bilirubin level should be intervened early in order to avoid occurrence of subclinical bilirubin brain injury. Brain MRI can detect subclinical bilirubin brain damage and therefore allow for early treatment and better prognosis.